SCHEMBL903955

SCHEMBL903955

CC(C)(C)OC(=O)N1CCC2(CC1)CC(Oc1c(F)cc(-c3ccc(S(C)(=O)=O)cc3)cc1F)C2

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10067698 0.80 GPR119 (0.45) GPR119
SCHEMBL903902 0.79 GPR119 (0.45) GPR119
SCHEMBL903887 0.78 GPR119 (0.53) GPR119
SCHEMBL1938312 0.77 GPR119 (0.61) GPR119
SCHEMBL30490303 0.74 GPR119 (0.54) GPR119
SCHEMBL903951 0.74 GPR119 (0.60) GPR119
SCHEMBL1474406 0.74 KDM1A (0.49) GPR119
SCHEMBL903936 0.74 GPR119 (0.48) GPR119
SCHEMBL30801902 0.73 GPR119 (0.53) GPR119
SCHEMBL30801945 0.73 GPR119 (0.52) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012041158-A1 TRICYCLIC COMPOUND, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-04-05 WO disclosed